BioNTech, Pfizer ask U.S. court for clearance over patent dispute with CureVac

CureVac NV

26/07/2022 13:15

FRANKFURT, July 26 (Reuters) - COVID-19 vaccine maker
Biontech  22UAy.DE  said on Tuesday that it and partner Pfizer
 PFE.N  have filed a complaint with the U.S. District Court in
Massachusetts, seeking a judgment that they did not infringe
U.S. patents held by rival CureVac  5CV.DE . 
    CureVac earlier this month filed a patent lawsuit in Germany
against BioNTech over its use of mRNA technology and did not
rule out further legal action against BioNTech's partner Pfizer 
or rival mRNA vaccine maker Moderna  MRNA.O . urn:newsml:reuters.com:*:nL8N2YM300

 (Reporting by Ludwig Burger, editing by Kirsti Knolle)
 ((ludwig.burger@thomsonreuters.com; +49 30 220133634;))